Key facts
- This page summarizes John P. Brancaccio's Form 4 filing for OKYO Pharma Ltd (OKYO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 23 Jul 2026, 16:15.
John P. Brancaccio - 21 Jul 2026 Form 4 Insider Report for OKYO Pharma Ltd (OKYO)
- Reporting relationship
- Director
- Issuer ticker
- OKYO
- Reported as of
- 21 Jul 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Jul 2026, 16:15:24 UTC
- Prior SEC filing
- 10 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Brancaccio
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John P. Brancaccio filed Form 4 for OKYO Pharma Ltd (OKYO) on 23 Jul 2026.
Change
- Previous filing in this sequence was filed on 10 Jun 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001276551
Primary reporting owner
BRANCACCIO JOHN P
- Relationship
- Director
- Address
- 14-15 CONDUIT ST, LONDON, UNITED KINGDOM
- Signature
- /s/ John Brancaccio
- Signature date
- 23 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OKYO
transaction
COMMON STOCK
Award
- Transaction value
- Shares
- +5,000
- Change %
- +17%
- Price
- $1.48*
- Shares after
- 35,201
- Date
- 21 Jul 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.